Home › Funds › TCG Crossover Management, LLC › TNGX

TCG Crossover Management, LLC position in TNGX

TANGO THERAPEUTICS INC · Health Care

TCG Crossover Management, LLC reported holding 6,773,043 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$169.0M, representing 4.77% of its reported portfolio and ranking #5 among its reported holdings. TCG Crossover Management, LLC has disclosed TNGX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)6.77M sh
Reported value held$168.99M
Portfolio Weight4.77%
First reportedQ4 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's TNGX position evolved

TCG Crossover Management, LLC first disclosed a stake in TNGX in Q4 2024 at 10,736,000 shares (US$33.2M). The position peaked in Q2 2026 at 9,081,201 shares, worth US$283.9M. Across 8 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 6,773,043 shares valued at US$169.0M — a reduction of -2,308,158 shares quarter over quarter.. Notable position changes include a 50% increase in Q4 2025 (shares rose 136% over the following quarter), a 25% trim in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 10.74M $33.17M New
Q1 2025 10.74M $14.71M Hold
Q2 2025 10.74M $54.97M Hold
Q3 2025 8.54M $71.70M Reduce
Q4 2025 12.76M $113.07M Add
Q1 2026 10.53M $220.31M Reduce
Q2 2026 9.08M $283.88M Reduce
Q3 2026 6.77M $168.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TNGX and 13F data

TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 69 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$340.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TNGX

All TNGX fund holders →

FAQ

How long has TCG Crossover Management, LLC held TNGX?

TCG Crossover Management, LLC has disclosed TNGX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is TCG Crossover Management, LLC's current position in TNGX?

As of Q3 2026, TCG Crossover Management, LLC holds 6.77M shares of TNGX (TANGO THERAPEUTICS INC), valued at $168.99M, representing 4.77% of its reported portfolio and ranking #5.

Has TCG Crossover Management, LLC been buying or selling TNGX?

In the latest 13F filing (Q3 2026), TCG Crossover Management, LLC reduced its position in TNGX. The position peaked in Q2 2026 at 9.08M shares.

Which other funds hold TNGX?

Other major institutional holders of TNGX include Farallon Capital Management, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 69 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.